ID
Idorsia
IDIA.SW·SIXAllschwil CHFounded 2017500 employees
Small CappharmaPublicCNSCardiology
Platform: Daridorexant Insomnia
Market Cap
$0.4B
All Drugs
2
Clinical Trials
6
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (IDIA.SW)
Loading IDIA.SW stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| IDI-7416 | IDI-7416 | Phase 2 | 2 | GLP-1R | HNSCCOvarian Ca | ||
| IDI-2657 | IDI-2657 | Approved | 4 | FGFR | Melanoma |
SEC Filings & Financial Documents
SEC filings are not available for SIX-listed companies.
Idorsia trades on SIX (CH). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (5)